UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines

Gastric Cancer, 2016-01, Vol.19 (1), p.3-14

2016

Link zum Volltext

Verfügbarkeit prüfen

Gastrointestinal stromal tumours

Nature reviews. Disease primers, 2021-03, Vol.7 (1), p.22-22, Article 22

2021

Link zum Volltext

Verfügbarkeit prüfen

Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?

Journal for immunotherapy of cancer, 2019-03, Vol.7 (1), p.85-85, Article 85

2019

Link zum Volltext

Verfügbarkeit prüfen

Deep learning-based classification of mesothelioma improves prediction of patient outcome

Nature medicine, 2019-10, Vol.25 (10), p.1519-1525

2019

Link zum Volltext

Verfügbarkeit prüfen

Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first‐line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

Cancer, 2020-06, Vol.126 (11), p.2637-2647

2020

Link zum Volltext

Verfügbarkeit prüfen

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations

The New England journal of medicine, 2015-08, Vol.373 (8), p.726-736

2015

Link zum Volltext

Verfügbarkeit prüfen

Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial

The Lancet (British edition), 2016-04, Vol.387 (10028), p.1629-1637

2016

Link zum Volltext

Verfügbarkeit prüfen

Mortality of patients with solid and haematological cancers presenting with symptoms of COVID-19 with vs without detectable SARS-COV-2: a French nationwide prospective cohort study

British journal of cancer, 2021-08, Vol.125 (5), p.658-671

2021

Link zum Volltext

Verfügbarkeit prüfen

Radiotherapy in bone sarcoma: the quest for better treatment option

BMC cancer, 2023-08, Vol.23 (1), p.742-742, Article 742

2023

Link zum Volltext

Verfügbarkeit prüfen

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial

The lancet oncology, 2017-06, Vol.18 (6), p.812-822

2017

Link zum Volltext

Verfügbarkeit prüfen

Primary Retroperitoneal Sarcomas: A Multivariate Analysis of Surgical Factors Associated With Local Control

Journal of clinical oncology, 2009-01, Vol.27 (1), p.31-37

2009

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis

Cancer, 2012-03, Vol.118 (6), p.1649-1655

2012

Link zum Volltext

Verfügbarkeit prüfen

Randomized Multicenter and Stratified Phase II Study of Gemcitabine Alone Versus Gemcitabine and Docetaxel in Patients with Metastatic or Relapsed Leiomyosarcomas: A Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study)

The oncologist (Dayton, Ohio), 2012-09, Vol.17 (9), p.1213-1220

2012

Link zum Volltext

Verfügbarkeit prüfen

Incidence of Soft Tissue Sarcoma and Beyond: A Population-Based Prospective Study in 3 European Regions

Cancer, 2012-11, Vol.118 (21), p.5339-5348

2012

Link zum Volltext

Verfügbarkeit prüfen

Management of sarcoma patients: centralization in reference centers to fragmentation of systemic treatment

Current opinion in oncology, 2018-07, Vol.30 (4), p.240-242

Blay, Jean-Yves

2018

Link zum Volltext

Verfügbarkeit prüfen

Health‐related quality‐of‐life results from PALETTE: A randomized, double‐blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy—a European Organization for research and treatment of cancer soft tissue and bone sarcoma group global network study (EORTC 62072)

Cancer, 2015-09, Vol.121 (17), p.2933-2941

2015

Link zum Volltext

Verfügbarkeit prüfen

Early morning immune checkpoint blockade and overall survival of patients with metastatic cancer: An In-depth chronotherapeutic study

European journal of cancer (1990), 2024-03, Vol.199, p.113571-113571, Article 113571

2024

Link zum Volltext

Verfügbarkeit prüfen

Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomas

Oncoimmunology, 2020-01, Vol.9 (1), p.1747340-1747340

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.190

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.124)
Mit Volltextzugriff
(1.052)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.089)
Japanisch
(128)
Französisch
(111)
Deutsch
(3)
Norwegisch
(1)
Russisch
(1)

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines

Gastrointestinal stromal tumours

Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?

Deep learning-based classification of mesothelioma improves prediction of patient outcome

Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first‐line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations

Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial

Mortality of patients with solid and haematological cancers presenting with symptoms of COVID-19 with vs without detectable SARS-COV-2: a French nationwide prospective cohort study

Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial

Radiotherapy in bone sarcoma: the quest for better treatment option

Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial

Primary Retroperitoneal Sarcomas: A Multivariate Analysis of Surgical Factors Associated With Local Control

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis

Randomized Multicenter and Stratified Phase II Study of Gemcitabine Alone Versus Gemcitabine and Docetaxel in Patients with Metastatic or Relapsed Leiomyosarcomas: A Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study)

Incidence of Soft Tissue Sarcoma and Beyond: A Population-Based Prospective Study in 3 European Regions

Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma: A study from TARPSWG

Management of sarcoma patients: centralization in reference centers to fragmentation of systemic treatment

Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2 -amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study

Early morning immune checkpoint blockade and overall survival of patients with metastatic cancer: An In-depth chronotherapeutic study

Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomas

Presentation and outcome of frequent and rare sarcoma histologic subtypes: A study of 10,262 patients with localized visceral/soft tissue sarcoma managed in reference centers

Suchergebnisse filtern